What are the Challenges in Targeting Growth Factors?
Despite the success of targeted therapies, there are significant challenges. Cancer cells can develop resistance to these drugs through various mechanisms, such as mutations in the growth factor receptors or activation of alternative signaling pathways. Additionally, the redundancy and complexity of these pathways make it difficult to achieve complete inhibition.
